secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lyra Therapeutics, Inc. (LYRA)
CIK:        0001327273
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001193125-25-122485
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lyra Therapeutics approves 1-for-50 reverse stock split, effective May 27
-------------------------------------------------------------------------

- Stockholders approved reverse-split authority at 1-for-10 to 1-for-50 range; Board set final ratio at 1-for-50.
- Reverse split effective 5:00 p.m. ET May 27, 2025; split-adjusted trading starts May 28 under symbol LYRA.
- No fractional shares issued; holders receive cash payment based on May 27 closing price.
- CUSIP changes to 55234L204 after split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1327273/000119312525122485/0001193125-25-122485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1327273/000119312525122485/d932010d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-122485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer